Access TOC
Get a SampleDecember 2023
The global skin antiseptic products market size was USD 3.20 billion in 2023, estimated at USD 3.42 billion in 2024 and is anticipated to reach around USD 6.50 billion by 2034, expanding at a CAGR of 6.64% from 2024 to 2034.
The global skin antiseptic products market size accounted for USD 3.42 billion in 2024 and is predicted to reach around USD 6.50 billion by 2034, growing at a CAGR of 6.64% from 2024 to 2034.
The U.S. skin antiseptic products market size was valued at USD 760 million in 2023 and is expected to be worth around USD 1,560 billion by 2034, growing at a CAGR of 7% from 2024 to 2034.
Based on region, North America dominated the global skin antiseptic products market in 2023, in terms of revenue and is estimated to sustain its dominance during the forecast period. The increased penetration of healthcare units coupled with rising number of surgeries being performed in the region is driving the growth of the market. Further, growing geriatric population, rising burden of diseases, rising investment by the market players for the development of innovative products, and rising adoption for surgeries among the population of North America are the various factors accountable for driving the growth of the market.
On the other hand, Asia Pacific is estimated to be the most opportunistic market during the forecast period. This is attributable to the rising penetration of hospitals and clinics in the region, rising government expenditure on building hospitals, lack of proper cleaning and sanitization in hospitals, and increasing number of patients in the region. The presence of huge population with rising number of accidents on road is propelling the use of skin antiseptics in the emergency ward of hospitals. Therefore, this region is expected to grow at a rapid rate during the forecast period.
The skin antiseptic products are extensively used in the hospitals, clinics, and surgical units owing to the increased risks of hospital acquired infections. The lack of proper sanitization in healthcare units is a major driver of the global skin antiseptic products market. According to a data published by the Centres for Disease Control and Prevention, around 4% of the hospital patients has one healthcare acquired infection. The usage of skin antiseptic products prevents and reduces the chances of hospital acquired infections. Therefore, hospital acquire infection is one of the major drivers of the skin antiseptic products of market across the globe. The growth and penetration of healthcare units across the globe coupled with rising government expenditure on building hospitals and sophisticated healthcare infrastructure is positively contributing towards the growth of the global skin antiseptic market.
Demand for the alcohol skin antiseptics is rising for pre-operative and pre-injection skin preparation. The rising technological innovations and rising popularity of various minimal invasive surgeries is boosting the consumption of skin antiseptic products across the globe. Further, the consumer or the patients are increasingly opting for the minimal invasive surgeries owing to their increased faith in technological advancements for the treatment of various diseases. The rising consumer expenditure on health and wellness coupled with rising disposable income of the consumers is indirectly boosting the growth of the global skin antiseptic products market.
The outbreak of COVID-19 and the COVID-19 vaccination drive across the globe had boosted the demand for the skin antiseptic products to a certain level. Increased usage of antiseptics for pre-injection skin preparation during COVID-19 vaccination positively impacted the consumption of alcohol skin antiseptics across the globe. The huge global population is expected to boost the consumption of skin antiseptic products in the upcoming years as the vaccination will require huge volume of antiseptics. Therefore, the global skin antiseptic products market is expected to witness positive growth in the foreseeable future.
| Report Highlights | Details |
| Market Size in 2023 | USD 3.20 Billion |
| Market Size in 2024 | USD 3.42 Billion |
| Market Size by 2034 | USD 6.50 Billion |
| Growth Rate from 2024 to 2034 | CAGR of 6.64% |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2034 |
| Segments Covered | Type, Formulation, Application, Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Based on type, the solutions segment dominated the global skin antiseptic products market in 2023, in terms of revenue and is estimated to sustain its dominance during the forecast period. This is attributed to the extensive usage of solutions in the pre-injection and pre-operative skin preparation in hospitals, clinic, and other healthcare units all over the globe. Solutions are the most common and most effective type of skin antiseptic used for the effective prevention of hospital acquired infections, thereby fostering the segment growth.
On the other hand, the wipes segment is expected to be the fastest-growing segment during the forecast period. This is attributable to the convenience of use associated with the use of wipes. It is easy to use and helps in film adhesion. Moreover, the wipes are very effective in cleaning the wounds. Hence, this segment is expected to grow rapidly during the forecast period.
Based on formulation, the alcohol segment dominated the global skin antiseptic products market in 2023, in terms of revenue and is estimated to sustain its dominance during the forecast period. This is attributed to the extreme popularity of the alcohol for its effective antiseptic property across the globe. Further, alcohol based solutions and wipes are extensively used in the pre-injection and pre-operative skin preparation and popularly used for cleaning wounds. Hence, the higher usage of alcohol as an antiseptic made this segment the dominating segment in the global market.
On the other hand, octenidine segment is estimated to be the most opportunistic segment during the forecast period. It is commonly used as an alternative to the iodine and chlorhexidine as the use of iodine and chlorhexidine are banned in certain nations. In US, the Food and drug Administration has restricted the usage of chlorhexidine and iodine, therefore the use of octenidine as a substitute is a major factor that propels the growth of this segment.
Based on application, the injection segment dominated the global skin antiseptic products market in 2023, in terms of revenue and is estimated to sustain its dominance during the forecast period. This is attributable to the increased usage of injections for injecting medicines, extracting fluids, and extracting blood.
Sometimes, injections are used by the individuals suffering from injuries and pains. For this reason, the injection is also expected to be the fastest-growing segment during the forecast period.
The market is moderately fragmented with the presence of several local companies. These market players are striving to gain higher market share by adopting strategies, such as investments, partnerships, and acquisitions & mergers. Companies are also spending on the development of improved products. Moreover, they are also focusing on maintaining competitive pricing.
In February 2019, Schulke&Mayr GmbH entered into an agreement with DKSH for the distribution of its products.
The various developmental strategies like new product launches with latest and innovative features fosters market growth and offers lucrative growth opportunities to the market players.
Segments Covered in the Report
By Type
By Formulation
By Application
By Geography
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
December 2023
November 2024
October 2024
January 2024